Stay Connected. Stay Informed.
Rajeev Singh Raghuvanshi. File India’s drug regulator Drugs Controller General of India (DCGI) on Wednesday (October 9, 2024) said manufacturers of around 45 medicines have been ordered to recall their products for not meeting quality norms, while action has been initiated to book the makers of five spurious drugs. In an interaction with reporters on…
The DCGI said the company made claims for the product for which it had not obtained approval New Delhi: Taking serious note of Mumbai-based Entod Pharmaceuticals’ claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company…
Read More “After Pharma Firm’s Huge Eye Drop Claim, Regulator Withdraws Permission” »
Abbott India informed drug controller Central Drugs Standard Control Organisation of the voluntary recall of Digene Gell and stopped production of all variants of the product manufactured at their Goa facility. Photo: digeneindia.com The Central Drugs Standard Control Organisation (CDSCO) has alerted healthcare professionals, consumers, patients, wholesalers, distributors, and regulatory authorities about the voluntary recall of…
